Urinary matrix metalloproteinases-2/9 in healthy infants and haemangioma patients prior to and during propranolol therapy. (Record no. 21422812)

MARC details
000 -LEADER
fixed length control field 01470 a2200421 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250516071900.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201210s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1432-1076
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1007/s00431-011-1660-x
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Kleber, C J
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20121017
245 00 - TITLE STATEMENT
Title Urinary matrix metalloproteinases-2/9 in healthy infants and haemangioma patients prior to and during propranolol therapy.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. European journal of pediatrics
Date of publication, distribution, etc. Jun 2012
300 ## - PHYSICAL DESCRIPTION
Extent 941-6 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adrenergic beta-Antagonists
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Age Factors
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Biomarkers
General subdivision urine
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Case-Control Studies
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Administration Schedule
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Hemangioma
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Infant
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Matrix Metalloproteinase 2
General subdivision urine
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Matrix Metalloproteinase 9
General subdivision urine
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Propranolol
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Treatment Outcome
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Spiess, A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kleber, J B
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Hinz, U
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Holland-Cunz, S
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Weiss, J
773 0# - HOST ITEM ENTRY
Title European journal of pediatrics
Related parts vol. 171
-- no. 6
-- p. 941-6
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1007/s00431-011-1660-x">https://doi.org/10.1007/s00431-011-1660-x</a>
Public note Available from publisher's website

No items available.